Inpharma

Can statins operate as neuroprotective agents?
pp. 2-2(1)

Effects of neutralising antibodies against interferons in MS
pp. 3-3(1)

Emerging treatment options for bipolar disorder
pp. 3-3(1)

Emergency contraceptive pills should be available OTC
pp. 3-3(1)

Physicians may be able to avoid unnecessary antibacterial prescribing for children
pp. 4-4(1)

Micronised progesterone: greater QOL in postmenopausal women
pp. 4-4(1)

Choose lamivudine over interferon- for best deal in hepatitis B
pp. 4-4(1)

Linezolid low-cost option for cellulitis in the UK
pp. 5-6(2)

Fluticasone propionate more cost effective than zafirlukast for asthma
pp. 6-6(1)

Enoxaparin sodium cost effective for VTE prevention
pp. 6-6(1)

Urotensin II: potential renal, cardiovascular therapeutic target?
pp. 7-7(1)

Rituximab may be beneficial in chronic refractory ITP
pp. 7-7(1)

Brimonidine vs betaxolol: QOL impact in treating elevated IOP
pp. 7-7(1)

Temoporfin-mediated photodynamic therapy shows efficacy in the treatment of BCC
pp. 8-8(1)

Thalidomide alleviates cytopenias in some patients with MDS
pp. 8-8(1)

Adefovir dipivoxil successfully treated HBV-associated fibrosing cholestatic hepatitis
pp. 8-8(1)

TRA-8: antitumour activity without hepatocyte toxicity
pp. 8-8(1)

Levodopa + physiotherapy improves motor recovery in stroke
pp. 9-9(1)

WNK kinases potential targets for new antihypertensives
pp. 9-9(1)

Yttrium-90 DOTATOC beneficial in neuroendocrine tumours
pp. 9-9(1)

Conjugated linoleic acid may be effective in reducing abdominal obesity
pp. 9-9(1)

It is safe to stop secondary antifungal prophylaxis against cryptococcosis
pp. 10-10(1)

Postoperative chemoradiotherapy beneficial in gastric cancer
pp. 10-10(1)

Chemoradiotherapy superior to radiotherapy in cervical cancer
pp. 10-10(1)

Dihydroergocryptine is effective for the treatment of patients with restless legs syndrome
pp. 10-10(1)

HERO-2: bivalirudin benefits patients with MI
pp. 11-12(2)

Allopurinol was used successfully to treat acquired reactive perforating collagenosis
pp. 12-12(1)

ACE inhibitors first choice in nondiabetic renal disease?
pp. 12-12(1)

Valproate semisodium may be a viable treatment for autism spectrum disorders
pp. 12-12(1)

Gemcitabine gives encouraging results in patients with advanced soft tissue sarcomas
pp. 12-12(1)

Single-dose Japanese encephalitis vaccine effective
pp. 13-13(1)

The addition of tramadol improves postoperative analgesia provided by caudal bupivacaine
pp. 13-13(1)

Diclofenac/misoprostol superior in hip and knee OA
pp. 13-13(1)

Alendronic acid beneficial in GH deficiency + osteoporosis?
pp. 13-13(1)

Various triple therapy schedules seem equally effective in antiretroviral-naive adults
pp. 14-14(1)

Intravesical bacillus Calmette-Guérin (BCG) effectively prevents the recurrence of bladder cancer
pp. 14-14(1)

Success without corticosteroids in paediatric renal transplantation
pp. 14-14(1)

Is venlafaxine therapy viable in major depression and GAD?
pp. 14-14(1)

Atosiban may be effective for the primary prevention of preterm labour
pp. 14-14(1)

Tenecteplase plus enoxaparin sodium: MI therapy reaches new heights in ASSENT-3
pp. 15-16(2)

Basiliximab may be beneficial for treatment-refractory chronic atopic dermatitis
pp. 16-16(1)

Low-dose methotrexate may be a better treatment option for cutaneous LCH
pp. 16-16(1)

Fluoxetine for OCD in paediatric patients?
pp. 16-16(1)

Carboplatin plus gemcitabine followed by paclitaxel is a well tolerated sequential regimen
pp. 17-17(1)

Sertraline + clonazepam shows efficacy early in panic disorder
pp. 17-17(1)

Gatifloxacin and levofloxacin are equally effective in uncomplicated SSTIs
pp. 17-17(1)

Letrozole may be beneficial in patients with low-grade endometrial stromal sarcoma
pp. 17-17(1)

Lamivudine beneficial in paediatric post-transplant HBV infection
pp. 17-17(1)

Bisoprolol beneficial following major vascular surgery
pp. 18-18(1)

Valproate semisodium + lamotrigine looks good in frontal lobe epilepsy
pp. 18-18(1)

Sibutramine combined with a diet and exercise programme enhances bodyweight loss
pp. 18-18(1)

Advanced squamous carcinomas may be effectively treated with a triple-drug regimen
pp. 18-18(1)

A new mechanism of atorvastatin beneficial in CAD?
pp. 19-19(1)

Glycyrrhizin reduces ALT in chronic hepatitis C
pp. 19-19(1)

Naltrexone improves ovulation induction in PCOS
pp. 19-19(1)

The risk of chloroquine- or hydroxychloroquine-induced vision disorders appears to be low
pp. 20-20(1)

Rifampicin + pyrazinamide-induced hepatitis - TB guidelines updated
pp. 20-20(1)

Folic acid enhances endothelial function in CAD
pp. 20-20(1)

The serum concentration of olanzapine is increased by fluvoxamine, but not sertraline
pp. 20-20(1)

Risk of miscarriage not increased with folic acid
pp. 21-21(1)

Propofol contraindicated in patients aged 16 years in UK
pp. 21-21(1)

Serious ADRs with use of nevirapine in HIV PEP
pp. 21-21(1)

US market news
pp. 22-22(1)

AstraZeneca's local anaesthetic agent ropivacaine [`Anapeine'] has been launched in Japan
pp. 22-22(1)

MCA says Psoralea corylifolia products `should not be used'
pp. 22-22(1)

Orlistat for 1 year appears `safe from a bone preserving point of view'
pp. 22-22(1)